This study demonstrated that MSCs release inflammatory cytokines, particularly the C‐C motif chemokine ligand 5 (CCL5), which significantly stimulate the expression of PD‐L1 in breast cancer cells, thus creating an inhibitory immune microenvironment.84 This evidence concerns the gene CD274 and breast carcinoma.